Reich, K <br/><br/>
Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study.  [electronic resource] 

 -  The British journal of dermatology  Oct 2017 
 - 1014-1023 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1365-2133 
<br/><br/><label>Standard No.: </label>10.1111/bjd.15666  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Injections, Subcutaneous<br/>Male<br/>Patient Reported Outcome Measures<br/>Psoriasis--drug therapy<br/>Treatment Outcome<br/>Ustekinumab--administration & dosage